Impact of ICD-9 to ICD-10 Coding Transition on Prevalence Trends in Neurology
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 19, 2020
- Accepted October 28, 2020
- First Published January 29, 2021.
Article Versions
- Previous version (January 29, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Ali G. Hamedani, MD, MHS,
- Leah Blank, MD, MPH,
- Dylan P. Thibault, MS and
- Allison W. Willis, MD, MSCI
- Ali G. Hamedani, MD, MHS,
NONE
NONE
NONE
Editorial board member for CONTINUUM: Lifelong Learning in Neurology, 2017-2018
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NINDS T32 NS061779-10 (2018-2010)
NONE
Parkinson Study Group Mentored Clinical Research Award (2019-2020)
NONE
NONE
NONE
NONE
NONE
NONE
- Leah Blank, MD, MPH,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Pharmacoepidemiology Training Grant (T32-GM-075766)
NONE
(1) American Epilepsy Society / Epilepsy Foundation Junior Investigator Award (2) American Epilepsy Society/ New-onset refractory status epilepticus (NORSE) Foundation seed fund (3) Mirowski Family Fund
NONE
NONE
NONE
NONE
NONE
(1) Bristol Myers Squibb, spouse employed by a multinational law firm of whom BMS was a client in 2018- 2020.
- Dylan P. Thibault, MS and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Allison W. Willis, MD, MSCI
NONE
NONE
NONE
I have been an associate editor for the journal Pharmacoepidemiology and Drug Safety in August 2013.
NONE
NONE
NONE
NONE
NONE
Commercial. I am a site-investigator for an international multicenter clinical trial of a investigational drug for the treatment of Parkinson disease
NONE
NONE
National Institutes of Health/NINDS, R01 ns099129 Principle Investigator, September 2017- present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Department of Neurology and Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research (AGH, DPT), Perelman School of Medicine, University of Pennsylvania, Philadelphia; Departments of Neurology and Population Health Science and Policy (LB), Icahn School of Medicine at Mount Sinai, New York; and Departments of Neurology and of Biostatics and Epidemiology and Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research (AWW), Perelman School of Medicine, University of Pennsylvania, Philadelphia.
- Correspondence
Dr. Hamedani ali.hamedani{at}pennmedicine.upenn.edu
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.